Zai Lab Limited (ZLAB) Launches Hong Kong Secondary Listing

Go back to Zai Lab Limited (ZLAB) Launches Hong Kong Secondary Listing

Zai Lab Launches Hong Kong Secondary Listing

September 16, 2020 7:15 AM UTC

SHANGHAI and SAN FRANCISCO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (Zai Lab or the Company) (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced the launch of its Hong Kong public offering (the Hong Kong Public Offering), which forms part of the global offering (the Offering) of 10,564,050 new ordinary shares (the Offer Shares or Shares) and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the Hong Kong Stock Exchange) under the stock code 9688.

The Companys American depositary shares (ADSs), each representing one (1) ordinary share of the Company,... More